TY - JOUR
T1 - Factors influencing colorectal cancer screening decision-making among average-risk US adults
AU - Zhu, Xuan
AU - Weiser, Emily
AU - Griffin, Joan M.
AU - Limburg, Paul J.
AU - Finney Rutten, Lila J.
N1 - Funding Information:
We thank Debra J. Jacobson, MS, (Retired) from the Division of Clinical Trials and Biostatistics at Mayo Clinic for statistical support. Writing and administrative support were provided by William K. Johnson, PhD, MSc, an employee of Exact Sciences Corporation.
Publisher Copyright:
© 2022
PY - 2022/12
Y1 - 2022/12
N2 - Colorectal cancer (CRC) screening rates remain suboptimal in the US. We examined patient-focused concerns and influence of various factors (e.g., test attributes, provider recommendation) on CRC screening decision-making. We conducted a web survey with 1595 US adults aged 40–75 from a nationally representative panel in November 2019 (completion rate: 31.3 %). Analyses focused on individuals aged 45–75 years at average-risk for CRC (n = 1062). All participants rated their level of concern about various CRC screening test/procedure attributes. Participants who have screened previously designated the three most important attributes for choosing a screening method and rated how various factors influenced their decision to use a particular method. The top concern for participants who have not screened previously was having an invasive procedure (54.2 %) while the top concerns for participants who have screened previously were completing a colon prep (41.3 %) and test/procedure accuracy (41 %). Cost/insurance coverage was most frequently ranked among the most important attributes (48.5 %), followed by where the test can be taken (45.7 %) and test accuracy (43.6 %). Provider recommendation was reported as the major motivator across screening methods. Other factors that were frequently reported as very influential included convenience and comfort for the stool-based methods and scientific/clinical evidence and insurance coverage for colonoscopy. Variations by age, sex, and race/ethnicity were noted. Findings demonstrate that along with provider recommendation, patient preferences regarding test/procedure attributes and preparation requirements are influential in screening decision-making, highlighting the need for clinicians to involve patients in shared decision-making and incorporate patient needs and preferences in establishing screening strategies.
AB - Colorectal cancer (CRC) screening rates remain suboptimal in the US. We examined patient-focused concerns and influence of various factors (e.g., test attributes, provider recommendation) on CRC screening decision-making. We conducted a web survey with 1595 US adults aged 40–75 from a nationally representative panel in November 2019 (completion rate: 31.3 %). Analyses focused on individuals aged 45–75 years at average-risk for CRC (n = 1062). All participants rated their level of concern about various CRC screening test/procedure attributes. Participants who have screened previously designated the three most important attributes for choosing a screening method and rated how various factors influenced their decision to use a particular method. The top concern for participants who have not screened previously was having an invasive procedure (54.2 %) while the top concerns for participants who have screened previously were completing a colon prep (41.3 %) and test/procedure accuracy (41 %). Cost/insurance coverage was most frequently ranked among the most important attributes (48.5 %), followed by where the test can be taken (45.7 %) and test accuracy (43.6 %). Provider recommendation was reported as the major motivator across screening methods. Other factors that were frequently reported as very influential included convenience and comfort for the stool-based methods and scientific/clinical evidence and insurance coverage for colonoscopy. Variations by age, sex, and race/ethnicity were noted. Findings demonstrate that along with provider recommendation, patient preferences regarding test/procedure attributes and preparation requirements are influential in screening decision-making, highlighting the need for clinicians to involve patients in shared decision-making and incorporate patient needs and preferences in establishing screening strategies.
KW - Colonoscopy
KW - Colorectal cancer screening
KW - Fecal immunochemical test/guaiac-based fecal occult blood test
KW - Multi-target stool DNA
KW - Patient decision-making
UR - http://www.scopus.com/inward/record.url?scp=85141540138&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85141540138&partnerID=8YFLogxK
U2 - 10.1016/j.pmedr.2022.102047
DO - 10.1016/j.pmedr.2022.102047
M3 - Article
AN - SCOPUS:85141540138
VL - 30
JO - Preventive Medicine Reports
JF - Preventive Medicine Reports
SN - 2211-3355
M1 - 102047
ER -